Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China
This study provides a comprehensive characterization of CDI in hematological patients, highlighting the urgent need for enhanced surveillance and preventive strategies against this emerging nosocomial threat.
Authors
- Qi Zhao (ORCID: https://orcid.org/0000-0003-0840-677X)
- Xianglong Wei
- Beiwen Wei
- Hui Li (ORCID: https://orcid.org/0000-0003-2600-4838)
- Yuan Bian (ORCID: https://orcid.org/0000-0001-8559-2575)
- Zhen Song (ORCID: https://orcid.org/0000-0003-2322-9484)
- Jiewen Huang
- Qingtian Li (ORCID: https://orcid.org/0000-0003-1170-0806)
- Yanan Zhao
- Shuzhen Xiao
- Zizhen Xu (ORCID: https://orcid.org/0009-0008-2381-2614)
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Shanghai Mental Health Center (CN)
- Yuhuangding Hospital (CN)
- Baogang Group (China) (CN)
- Qingdao Eighth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.3389/fcimb.2025.1668584
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China